Successful validation of protein multiplexing technology platform Cologne, Germany, June 24, 2015 / B3C newswire / -- AYOXXA Biosystems and Grünenthal, a pain therapeutics specialist, have completed a first research collaboration to validate …
Maastricht, The Netherlands, 22 June, 2015 / B3C newswire / -- Cristal Therapeutics, a privately-held biopharmaceutical company developing novel therapeutics against cancer and other diseases by using its proprietary CriPec® platform, today announced the …
GMP manufacturing license extended further to the two new highly innovative cell and gene therapy products Two additional cleanroom areas for aseptic processing received GMP certification and put into operation Further expansion of apceth’s global GMP …
Vienna, Austria, June 19, 2015 / B3C newswire / -- AOP Orphan Pharmaceuticals AG announced today the regulatory submission of Tetrabenazine for the treatment of tardive dyskinesia in a DCP (decentralized procedure) for several European countries with UK …
Uppsala, Sweden, June 16, 2015 / B3C newswire / -- Biotage® (STO: BIOT), a leading global supplier of solutions and technology for analytical and medicinal chemistry, announces the addition of new polymer based SPE columns to their tried and tested EVOLUTE …
Laura van 't Veer, Ph.D., Honored as Inventor of MammaPrint® Breast Cancer Test Amsterdam, the Netherlands and Irvine, California, June 16, 2015 / B3C newswire / -- Agendia co-founder and Chief Research Officer, Laura van't Veer, Ph.D., has won the …
Life Sciences Report 2015: From rare to routine – medicines for rare diseases, vaccines and antibiotics published at BIO 2015 Research into new antibiotic classes represents less than five per cent of antibiotics-related patent filings Research into …
Budapest, Hungary, June 15, 2015 / B3C newswire / -- Sub-molecular cellular events, driven by hydrogen’s replacements with deuterium, explain medical and economical failures of targeted molecular cancer drugs, which are the main conclusions of the 3rd …
Dortmund, Germany, June 11, 2015 / B3C newswire / -- The Lead Discovery Center GmbH (LDC) and Johnson & Johnson Innovation Ltd., will collaborate to identify and accelerate innovative drug candidates for the treatment and prevention of diseases with …
The health research region Maastricht joins the Health Axis Europe. The four leading locations Cambridge (UK), Leuven (Belgium), Maastricht (Netherlands), and Heidelberg (Germany) form an alliance to foster innovation in health across Europe. Heidelberg, …
Citryll B.V. founded to accelerate tACPA development Oss, the Netherlands, June 11, 2015 / B3C newswire / -- ModiQuest B.V., a Dutch antibody drug development and diagnostics company focused on chronic inflammatory diseases, today announces that it has …
Continued demand and increased customer product transfers are generating a positive business outlook for the company’s early-stage development facility Skokie, USA, and Ravensburg, Germany, June 10, 2015 / B3C newswire / -- Vetter, a leading contract …
Munich, Germany, June 10, 2015 / B3C newswire / -- Isarna Therapeutics, the leader in transforming growth factor beta (TGF-ß) isoform targeted antisense therapeutics, today announced that the Food and Drug Administration (FDA) has granted orphan drug …
Ajdovšcina, Slovenia, June 8, 2015 / B3C newswire / -- BIA Separations, the world leading developer and manufacturer of CIM® (Convective Interaction Media) monolithic chromatographic columns and process development services strike partnership with Labena d …
Starting point of a broader drug discovery and development alliance Dortmund, Germany and Gyeonggi-do, South Korea, June 3, 2015 / B3C newswire / -- The Lead Discovery Center GmbH (LDC), a renowned translational drug discovery organization established by …
Test is first-to-market, non-invasive IVD assay for reliable detection of both Helicobacter pylori and clarithromycin resistance from stool sample Espoo, Finland, June 3, 2015 / B3C newswire / -- Mobidiag Ltd, a Finnish molecular diagnostics company …
Ajdovšcina, Slovenia, June 2, 2015 / B3C newswire / -- BIA Separations is proud to announce the expansion of its distribution network in China through collaboration with Guangzhou Bairui Medicine (hereinafter as Bairui). As of 15th May, BIA Separations…
"Production of the first ever batch of MVA for a clinical trial using a cell line" Berlin, Germany, June 2, 2015 / B3C newswire / -- Complex biologics development and manufacturing specialist ProBioGen today announced that an investigational …
May 29, 2015 / B3C newswire / -- In the German Center for Infection Research (DZIF), scientists from the universities of Tübingen, Münster and Munich join forces and prepare together with the company Hyglos clinical studies on an active substance against …
Vienna, Austria, May 28, 2015 / B3C newswire / -- As an easy-to-use and highly reliable inhalation powder, the antipsychotic ADASUVE® has revolutionized the treatment of agitation in patients suffering from schizophrenia or bipolar I disorder. This was …
